Warren Buffett fit · Wonderful businesses at fair prices
Is Anbio Biotechnology Class A Ordinary Shares (NNNN) a Warren Buffett Stock?
Low Buffett fit — meets only 4/9 criteria; valuation, moat, or financial health flags risk.
41/100
DNot a fit
4/9 criteria passed
Warren Buffett's Criteria, Applied to NNNN
ROIC ≥ 15%
key11.6%
Gross margin ≥ 40%
key89.7%
Owner earnings yield ≥ 5%
key1.0%
5y profitable
keyNo
Net Debt / EBITDA ≤ 3
-4.6x
Revenue CAGR ≥ 8%
-24.9%
EPS CAGR ≥ 8%
-48.3%
FCF / Net income ≥ 0.8
0.9x
Debt / Equity ≤ 1
0.0x
How NNNN Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.51B
P/E (TTM)
171.9x
ROIC (TTM)
21.48%
Gross margin
87.06%
Other Warren Buffett fit reports
Frequently Asked Questions
What is NNNN's Warren Buffett fit score?
NNNN scores 41/100 on our Warren Buffett fit engine — grade D. Low Buffett fit — meets only 4/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own NNNN?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends NNNN.
How often is this score updated?
NNNN's Warren Buffett fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends NNNN.